Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer. | Cell Rep Med | 2023 | 37797616 | PubTator, text mining | PubMed |
| Plasma proteomic associations with genetics and health in the UK Biobank. | Nature | 2023 | 37794186 | PubTator, text mining | PubMed |
| Biomedical engineering approaches for the delivery of JAGGED1 as a potential tissue regenerative therapy. | Front Bioeng Biotechnol | 2023 | 37781534 | PubTator, text mining | PubMed |
| Immunomodulation with IL-7 and IL-15 in HIV-1 infection. | J Virus Erad | 2023 | 37767312 | PubTator, text mining | PubMed |
| Defining the Basal and Immunomodulatory Mediator-Induced Phosphoprotein Signature in Pediatric B Cell Acute Lymphoblastic Leukemia (B-ALL) Diagnostic Samples. | Int J Mol Sci | 2023 | 37762241 | PubTator, text mining | PubMed |
| Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update. | Curr Oncol | 2023 | 37754534 | PubTator, text mining | PubMed |
| Type I interferon signature and cycling lymphocytes in macrophage activation syndrome. | J Clin Invest | 2023 | 37751296 | PubTator, text mining | PubMed |
| Hepatic T-cell senescence and exhaustion are implicated in the progression of fatty liver disease in patients with type 2 diabetes and mouse model with nonalcoholic steatohepatitis. | Cell Death Dis | 2023 | 37735474 | PubTator, text mining | PubMed |
| Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice. | Dis Model Mech | 2023 | 37718909 | PubTator, text mining | PubMed |
| Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation. | Exp Mol Med | 2023 | 37696896 | PubTator, text mining | PubMed |
| Co-Expression of an IL-15 Superagonist Facilitates Self-Enrichment of GD2-Targeted CAR-NK Cells and Mediates Potent Cell Killing in the Absence of IL-2. | Cancers (Basel) | 2023 | 37686586 | PubTator, text mining | PubMed |
| Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities. | Int J Mol Sci | 2023 | 37686020 | PubTator, text mining | PubMed |
| Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids. | Nat Commun | 2023 | 37684223 | PubTator, text mining | PubMed |
| Exploiting a rodent cell block for intrinsic resistance to HIV-1 gene expression in human T cells. | mBio | 2023 | 37676006 | PubTator, text mining | PubMed |
| Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative review. | Ann Transl Med | 2023 | 37675321 | PubTator, text mining | PubMed |
| Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function. | Cancer Immunol Res | 2023 | 37649085 | PubTator, text mining | PubMed |
| Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells. | Adv Pharm Bull | 2023 | 37646058 | PubTator, text mining | PubMed |
| SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and/or bystander activation of the immune system. | Bioimpacts | 2023 | 37645029 | PubTator, text mining | PubMed |
| M-CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation. | EMBO Mol Med | 2023 | 37635627 | PubTator, text mining | PubMed |
| Dendritic Cell-Derived Exosomes in Cancer Immunotherapy. | Pharmaceutics | 2023 | 37631284 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=12